Page 6 - Electrocore Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The global Neurostimulation Devices market is expected to witness significant growth due to the upsurge in chronic diseases, rising shift from...

/PRNewswire/ -- The "Global Neurostimulation Technologies Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global...

Share this article LAS VEGAS, April 29, 2021 /PRNewswire/ -- DelveInsight's Endoscopy Fluid Management Systems Market Insights, Competitive Landscape and Market Forecast -2026 provides the current and forecast market of the Endoscopy Fluid Management Systems and comprises of market trends and key competitors of Endoscopy Fluid Management Systems. DelveInsight estimated the market to grow at a steady CAGR over the study period of 2018 – 2026.  Endoscopy helps surgeons and clinicians to properly diagnose and perform surgery for various chronic and acute diseases. During the procedure, bot...

GammaCore Sapphire will be distributed in Canada by  RSK Medical Inc, under an exclusive distribution agreement announced in January this year. The initial term of the agreement is three years. In February this year, the FDA approved an expanded label of gammaCore nVNS to include the acute and preventive treatment of migraine in adolescents between 12 and 17.  GammaCore non-invasive vagus nerve stimulator is a non-invasive, hand-held medical therapy applied at the neck as an adjunctive therapy to treat migraine and cluster headache. It utilizes mild electrical stimulation to the vagus ne...

The Australian Therapeutic Goods Administration has approved ElectroCore Inc's (NASDAQ: ECOR) gammaCore Sapphire family of products, ...